MiR-548 acts as an anti-oncogenic factor that inhibits the phosphoinositide three-kinase (PI3K)/AKT signaling pathway in lung cancer and is associated with high-risk Gleason scores in PCa (Shi et al., 2015). This evidence concerns the gene AKT1 and lung carcinoma.